This study investigated the mechanisms underlying the transformation of an IDH2/R140Q mutant TF-1 cell line from the perspective of malignant proliferation to identify new potential targets for the treatment of IDH2-mutated AML. This evidence concerns the gene IDH2 and acute myeloid leukemia.